These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 10743073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M, Yu LL, Cai LQ, Wang HB, Wang ZH, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 5. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H, Scorilas A.
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [Abstract] [Full Text] [Related]

  • 6. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
    Wang J, Liu X, Jiang W.
    Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
    [Abstract] [Full Text] [Related]

  • 7. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.
    Gynecol Oncol; 2001 Jun 15; 81(3):380-90. PubMed ID: 11371126
    [Abstract] [Full Text] [Related]

  • 13. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK, Xing H, Zheng F, Gao QL, Wang W, Lu YP, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar 15; 38(3):158-61. PubMed ID: 12816691
    [Abstract] [Full Text] [Related]

  • 14. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
    Thomadaki H, Scorilas A.
    Biol Chem; 2008 Nov 15; 389(11):1427-34. PubMed ID: 18783338
    [Abstract] [Full Text] [Related]

  • 15. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A.
    Clin Cancer Res; 2007 Dec 01; 13(23):7191-8. PubMed ID: 18056200
    [Abstract] [Full Text] [Related]

  • 16. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
    Qin TN, Wang LL.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr 01; 22(4):344-6. PubMed ID: 12390742
    [Abstract] [Full Text] [Related]

  • 17. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M, Louis MH, Dutoit S, Brotin E, Lincet H, Duigou F, Staedel C, Gauduchon P, Poulain L.
    Gynecol Oncol; 2007 Apr 01; 105(1):31-44. PubMed ID: 17275076
    [Abstract] [Full Text] [Related]

  • 18. [Peroxisome proliferator activated receptor gamma coactivator-1 induces apoptosis in human epithelial ovarian cancer cells].
    Ba Y, Zhang Y, Zhang CY.
    Zhonghua Yi Xue Za Zhi; 2007 May 29; 87(20):1430-3. PubMed ID: 17785072
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 29; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 20. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
    Padilla LA, Leung BS, Carson LF.
    Gynecol Oncol; 2002 Apr 29; 85(1):59-66. PubMed ID: 11925121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.